植物由来API市場- 世界の市場規模、シェア、動向、機会、予測、分子タイプ別、エンドユーザー別、地域別、競合別、2020年～2030年

植物由来APIの世界市場規模は2024年に314億米ドル、2030年には445億2,000万米ドルに達すると予測、CAGRは5.95%。

世界の植物由来API市場は、技術革新、消費者主導型ヘルスケア需要の増加、慢性疾患の罹患率の上昇、予防医療への注目の高まりといった主要促進要因に後押しされ、大幅な成長を遂げています。血液検査や妊娠検査キットからグルコースモニターやアレルギー検査ソリューションに至るまで、植物由来API製品は個人の健康管理に不可欠なツールになりつつあります。これらの機器により、ユーザーは様々な健康パラメータを単独でモニターできるようになり、臨床を受診する必要がなくなり、消費者は自分の健康を管理できるようになります。

診断技術の進歩、消費者の健康意識の高まり、より手頃な価格で利用しやすく個別化された健康ソリューションへのシフトに支えられ、市場は堅調な成長を続けています。これらの植物由来API製品が健康管理戦略の中心的存在となるにつれ、市場は拡大し続けると予想されます。規制当局の支援と診断薬における継続的な技術革新が市場の潜在力をさらに高め、植物由来API分野はヘルスケアおよび診断薬業界の利害関係者にとって有利な機会と位置付けられています。

主要市場促進要因

天然・有機製品に対する需要の高まり

主な市場課題

規制の複雑さと統一基準の欠如

最も差し迫った課題の1つは、世界市場全体で植物由来APIに関する規制の枠組みが標準化・調和化されていないことです。

このような断片的な規制環境は、投資家や開発者に不確実性をもたらし、研究開発や国際的な事業展開を遅らせています。

主な市場動向

植物医薬品の主流医薬品開発への統合

この動向は、医薬品イノベーションにおけるパラダイムシフトを意味し、自然由来の原薬はもはや周辺的なものではなく、現代的な治療薬の中で戦略的に位置づけられるようになってきています。

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 植物由来API市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 分子タイプ別（アルカロイド、アントシアニン、フラボノイド、フェノール酸、テルペノイド、リグニン＆スチルベン、その他）
  • エンドユーザー別（医薬品、栄養補助食品、ハーブ系産業、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の植物由来API市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の植物由来API市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の植物由来API市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の植物由来API市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの植物由来API市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の植物由来API市場：SWOT分析

第14章 競合情勢

• Roquette Freres.
• Arboris, LLC
• Centroflora Group
• BASF SE
• Kothari Phytochemicals International
• Evonik Industries AG
• Brains
• Indo Phytochem Pharmaceuticals
• HimPharm.com
• Cargill, Incorporated

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Plant Based API market was valued at USD 31.40 Billion in 2024 and is expected to reach USD 44.52 Billion by 2030 with a CAGR of 5.95%. The global Plant Based API market is undergoing substantial growth, fueled by key drivers such as technological innovation, increasing demand for consumer-driven healthcare, the rising incidence of chronic diseases, and a growing focus on preventive care. Plant Based API products ranging from blood tests and pregnancy kits to glucose monitors and allergy testing solutions are progressively becoming integral tools for individuals managing their own health. These devices enable users to monitor a variety of health parameters independently, eliminating the need for clinical visits and empowering consumers to take control of their health.

The market's growth trajectory remains robust, underpinned by advancements in diagnostic technologies, heightened consumer health consciousness, and a shift toward more affordable, accessible, and personalized health solutions. As these Plant Based API products become increasingly central to health management strategies, the market is expected to continue expanding. Regulatory support and ongoing innovations in diagnostics further enhance the market's potential, positioning the Plant Based API segment as a lucrative opportunity for stakeholders in the healthcare and diagnostics industries.

Key Market Drivers

Rising Demand for Natural and Organic Products

The surge in global demand for natural and organic products is a powerful and influential factor driving the growth of the plant-based active pharmaceutical ingredient (API) market. Sales of natural and organic products have demonstrated consistent upward momentum, with select categories showing exceptional performance. Notably, natural organic meat, fish, and poultry recorded a 13.1% year-over-year growth in 2024, while the organic dairy segment posted a 9.8% increase during the same period. These figures reflect a significant shift in consumer purchasing behavior, underscoring a strong preference for clean-label, sustainably sourced food products within high-consumption categories. Today's consumers are increasingly informed and health conscious. There is a marked preference for products perceived as "clean," chemical-free, and closer to nature. As a result, medications and supplements that are plant-based are seen as gentler on the body, safer for long-term use, and less likely to cause side effects. This perception fuels growing patient and consumer interest in natural-origin pharmaceuticals, creating strong demand for APIs derived from botanical sources. A recent study indicates that 80% of millennials factor in health benefits when making food choices, compared to 64% of baby boomers (individuals born between 1946 and 1964). Importantly, millennials evaluate health not only through the lens of physical wellness but also consider emotional and social well-being as integral to their dietary decisions highlighting a broader, more holistic approach to nutrition among this demographic. The global healthcare narrative is gradually moving away from reactive treatment toward preventive care and holistic wellness. Plant-based products, often associated with traditional healing systems and holistic health, are viewed as ideal for preventive care. Consequently, pharmaceutical companies are under increasing pressure to develop formulations that align with wellness trends, further pushing demand for plant-based APIs in both prescription and over-the-counter segments.

Key Market Challenges

Regulatory Complexity and Lack of Harmonized Standards

One of the most pressing challenges is the lack of standardized and harmonized regulatory frameworks for plant-based APIs across global markets.

Plant-based APIs are often categorized differently across regions ranging from herbal medicines to dietary supplements or even traditional remedies. This inconsistency complicates product registration, labeling, and market entry, particularly in regulated markets such as the U.S., EU, and Japan. Unlike synthetic APIs, which follow well-defined approval pathways, plant-based APIs require complex documentation of botanical origin, bioactive compound consistency, and clinical efficacy, which can vary depending on the source and preparation method. Complying with multiple sets of regulatory standards increases time-to-market and operational costs, particularly for SMEs and regional manufacturers attempting to scale globally.

This fragmented regulatory environment creates uncertainty for investors and developers, slowing R&D and international expansion.

Key Market Trends

Integration of Phytopharmaceuticals into Mainstream Drug Development

A significant trend reshaping the plant-based API market is the growing integration of phytopharmaceuticals into conventional drug pipelines. Historically, plant-based compounds were largely confined to traditional medicine or nutraceutical applications. However, this is changing as pharmaceutical companies recognize their potential for targeted therapeutic action with fewer side effects.

A rising number of plant-derived compounds are undergoing clinical trials, validating their efficacy for chronic and lifestyle-related diseases such as diabetes, cardiovascular disorders, cancer, and neurodegenerative conditions. Major pharmaceutical firms are partnering with biotech startups and research institutes to co-develop plant-based drugs leveraging natural product libraries for lead discovery and screening. Advances in extraction, purification, and delivery systems have allowed for the development of proprietary formulations, making plant-based APIs commercially attractive due to stronger IP protections and differentiated value propositions.

This trend signifies a paradigm shift in pharma innovation, where nature-based APIs are no longer peripheral but are being strategically positioned within modern therapeutics.

Key Market Players

• Roquette Freres.
• Arboris, LLC
• Centroflora Group
• BASF SE
• Kothari Phytochemicals International
• Evonik Industries AG
• Brains
• Indo Phytochem Pharmaceuticals
• HimPharm.com
• Cargill, Incorporated

Report Scope:

In this report, the Global Plant Based API Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Plant Based API Market, By Molecule Type:

• Alkaloids
• Anthocyanin
• Flavonoids
• Phenolic Acids
• Terpenoids
• Lignin & Stilbenes
• Others

Plant Based API Market, By End User:

• Pharmaceuticals
• Nutraceuticals
• Herbal Based Industries
• Others

Plant Based API Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Plant Based API Market.

Available Customizations:

Global Plant Based API market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Plant Based API Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Molecule Type (Alkaloids, Anthocyanin, Flavonoids, Phenolic Acids, Terpenoids, Lignin & Stilbenes, Others)
  • 5.2.2. By End User (Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Plant Based API Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Molecule
  • 6.2.2. By End User
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Plant Based API Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Molecule
      • 6.3.1.2.2. By End User
  • 6.3.2. Canada Plant Based API Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Molecule
      • 6.3.2.2.2. By End User
  • 6.3.3. Mexico Plant Based API Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Molecule
      • 6.3.3.2.2. By End User

7. Europe Plant Based API Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Molecule
  • 7.2.2. By End User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Plant Based API Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Molecule
      • 7.3.1.2.2. By End User
  • 7.3.2. United Kingdom Plant Based API Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Molecule
      • 7.3.2.2.2. By End User
  • 7.3.3. Italy Plant Based API Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Molecule
      • 7.3.3.2.2. By End User
  • 7.3.4. France Plant Based API Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Molecule
      • 7.3.4.2.2. By End User
  • 7.3.5. Spain Plant Based API Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Molecule
      • 7.3.5.2.2. By End User

8. Asia-Pacific Plant Based API Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Molecule
  • 8.2.2. By End User
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Plant Based API Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Molecule
      • 8.3.1.2.2. By End User
  • 8.3.2. India Plant Based API Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Molecule
      • 8.3.2.2.2. By End User
  • 8.3.3. Japan Plant Based API Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Molecule
      • 8.3.3.2.2. By End User
  • 8.3.4. South Korea Plant Based API Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Molecule
      • 8.3.4.2.2. By End User
  • 8.3.5. Australia Plant Based API Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Molecule
      • 8.3.5.2.2. By End User

9. South America Plant Based API Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Molecule
  • 9.2.2. By End User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Plant Based API Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Molecule
      • 9.3.1.2.2. By End User
  • 9.3.2. Argentina Plant Based API Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Molecule
      • 9.3.2.2.2. By End User
  • 9.3.3. Colombia Plant Based API Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Molecule
      • 9.3.3.2.2. By End User

10. Middle East and Africa Plant Based API Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Molecule
  • 10.2.2. By End User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Plant Based API Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Molecule
      • 10.3.1.2.2. By End User
  • 10.3.2. Saudi Arabia Plant Based API Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Molecule
      • 10.3.2.2.2. By End User
  • 10.3.3. UAE Plant Based API Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Molecule
      • 10.3.3.2.2. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Plant Based API Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Roquette Freres.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Arboris, LLC
• 14.3. Centroflora Group
• 14.4. BASF SE
• 14.5. Kothari Phytochemicals International
• 14.6. Evonik Industries AG
• 14.7. Brains
• 14.8. Indo Phytochem Pharmaceuticals
• 14.9. HimPharm.com
• 14.10.Cargill, Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer